Clinically proven to treat bladder weakness
A 26-week pilot study of women with stress urinary incontinence who followed the Innovotherapy treatment regimen for 12 weeks found significant improvement in their symptoms:
- An improvement in the amount of involuntary urine leaked over 1 hour in 93% of INNOVO® users after 4 weeks of treatment, where 60% were defined as dry1
- An average 74% reduction in involuntary urine loss over 24 hours after 12 weeks of treatment, where 86% of INNOVO® users were defined as dry or almost dry2
- An improvement in the Modified Oxford Score (standing position) after treatment with Innovotherapy, where 79% of patients had good or moderate pelvic floor muscle contractions at 12 weeks, compared with 6% at baseline1
Patients’ pelvic floor muscle contractility improved over 12 weeks of INNOVO® treatment
Download our Clinician Brochure
Learn more about the clinical study proving INNOVO®'s effectiveness.